Pan-Cancer Mapping of the Tumor Immune Landscape through Metagene Clustering and Predictive Modeling
Fuente:
arXiv
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Preprint |
| Pubblicazione: |
2026
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1866915896832819200 |
|---|---|
| author | Chatterjee, Soham |
| author_facet | Chatterjee, Soham |
| contents | As immunotherapies become standard cancer treatments, it is increasingly important to identify a patient's immune profile, which encompasses the activity of immune cells within the tumor microenvironment and the presence of specific biomarkers. However, we lack mechanistic explanations drivers of immune phenotypes. Despite advances in immune profiling with high-throughput sequencing, the mechanisms driving them remain unclear. This study aimed to identify novel, robust immune-related gene clusters (metagenes) and evaluate their prognostic significance and functional relevance across various pan-cancer types using a comprehensive computational pipeline. We acquired pan-cancer bulk RNA-seq and established immune subtypes from The Cancer Genome Atlas (TCGA). Using expression-based filtering and clustering of genes with ANOVA and Gaussian Mixture Model (GMM), we identified 48 unique metagenes. These metagenes achieved 87% accuracy in predicting the established subtypes. SHAP analysis revealed the most predictive metagenes per subtype, while functional enrichment analysis identified their associated pathways. Genes were ranked by differential expression between high- and low-expression groups. The metagenes revealed insights, including co-expression of immune activation and regulatory factors, links between cell cycle regulation and immune evasion, and dynamic microenvironment remodeling signatures. Kaplan-Meier survival analysis and multivariate Cox Regression revealed that many metagenes had prognostic value for overall survival. Overall, the metagenes represent coordinated biological programs across diverse cancer types, providing a foundation for developing robust, broadly applicable immuno-oncology biomarkers that extend beyond single-gene markers. They demonstrate prognostic value across cancer types and hold potential to guide immunotherapy treatment decisions. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2603_27145 |
| institution | arXiv |
| publishDate | 2026 |
| record_format | arxiv |
| spellingShingle | Pan-Cancer Mapping of the Tumor Immune Landscape through Metagene Clustering and Predictive Modeling Chatterjee, Soham Genomics Machine Learning As immunotherapies become standard cancer treatments, it is increasingly important to identify a patient's immune profile, which encompasses the activity of immune cells within the tumor microenvironment and the presence of specific biomarkers. However, we lack mechanistic explanations drivers of immune phenotypes. Despite advances in immune profiling with high-throughput sequencing, the mechanisms driving them remain unclear. This study aimed to identify novel, robust immune-related gene clusters (metagenes) and evaluate their prognostic significance and functional relevance across various pan-cancer types using a comprehensive computational pipeline. We acquired pan-cancer bulk RNA-seq and established immune subtypes from The Cancer Genome Atlas (TCGA). Using expression-based filtering and clustering of genes with ANOVA and Gaussian Mixture Model (GMM), we identified 48 unique metagenes. These metagenes achieved 87% accuracy in predicting the established subtypes. SHAP analysis revealed the most predictive metagenes per subtype, while functional enrichment analysis identified their associated pathways. Genes were ranked by differential expression between high- and low-expression groups. The metagenes revealed insights, including co-expression of immune activation and regulatory factors, links between cell cycle regulation and immune evasion, and dynamic microenvironment remodeling signatures. Kaplan-Meier survival analysis and multivariate Cox Regression revealed that many metagenes had prognostic value for overall survival. Overall, the metagenes represent coordinated biological programs across diverse cancer types, providing a foundation for developing robust, broadly applicable immuno-oncology biomarkers that extend beyond single-gene markers. They demonstrate prognostic value across cancer types and hold potential to guide immunotherapy treatment decisions. |
| title | Pan-Cancer Mapping of the Tumor Immune Landscape through Metagene Clustering and Predictive Modeling |
| topic | Genomics Machine Learning |
| url | https://arxiv.org/abs/2603.27145 |